Psyence Biomedical Ltd. (PBM) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 3.64M |
| Enterprise Value | -3.8M |
| P/E Ratio | 0 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 1.07 |
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.39 |
| Return On Equity | -0.59 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -6.92M |
| Net Income | -6.94M |
| Diluted EPS | 0 |
| Total Cash | 7.2M |
| Total Cash/Share | 0 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 14.62 |
| Book Value Per Share | 0 |
| 52-Week Change | -89.92 |
| 52-Week High | 468.36 |
| 52-Week Low | 1.92 |
| Moving Average 50 Days | 4.99 |
| Moving Average 200 Days | 44.37 |
| Average Volume | 2.62M |
| Shares Outstanding | 19,019 |
| % Held by Institutions | 10.22 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:6 |
| Last Split Date | February 02, 2026 |